skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 40,483  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
Material Type:
Article
Add to My Research

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline

BMJ (Online), 2020-01, Vol.368, p.l6890-l6890 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6890 ;PMID: 31948937

Full text available

2
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
Material Type:
Article
Add to My Research

Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

Journal of clinical epidemiology, 2014-07, Vol.67 (7), p.745-753 [Peer Reviewed Journal]

The Authors ;2014 The Authors ;2015 INIST-CNRS ;Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2014 ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2013.11.013 ;PMID: 24582946

Full text available

3
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies
Material Type:
Article
Add to My Research

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies

Health technology assessment (Winchester, England), 2012-09, Vol.16 (35), p.1-82 [Peer Reviewed Journal]

ISSN: 1366-5278 ;EISSN: 2046-4924 ;DOI: 10.3310/hta16350 ;PMID: 22989478

Full text available

4
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
Material Type:
Article
Add to My Research

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Critical care (London, England), 2019-06, Vol.23 (1), p.219-219, Article 219 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1364-8535 ;EISSN: 1466-609X ;DOI: 10.1186/s13054-019-2497-3 ;PMID: 31200780

Full text available

5
DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network
Material Type:
Article
Add to My Research

DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network

BMC medical research methodology, 2018-02, Vol.18 (1), p.24-24, Article 24 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s) 2018 ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/s12874-018-0482-1 ;PMID: 29482517

Full text available

6
ESMO-Magnitude of Clinical Benefit Scale version 1.1
Material Type:
Article
Add to My Research

ESMO-Magnitude of Clinical Benefit Scale version 1.1

Annals of oncology, 2017-10, Vol.28 (10), p.2340-2366 [Peer Reviewed Journal]

2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx310 ;PMID: 28945867

Full text available

7
Sparse data bias: a problem hiding in plain sight
Material Type:
Article
Add to My Research

Sparse data bias: a problem hiding in plain sight

BMJ (Online), 2016-04, Vol.352, p.i1981-i1981 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright BMJ Publishing Group LTD Apr 27, 2016 ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i1981 ;PMID: 27121591

Full text available

8
Methodology and reporting characteristics of studies using interrupted time series design in healthcare
Material Type:
Article
Add to My Research

Methodology and reporting characteristics of studies using interrupted time series design in healthcare

BMC medical research methodology, 2019-07, Vol.19 (1), p.137-137, Article 137 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/s12874-019-0777-x ;PMID: 31272382

Full text available

9
Five insights from the Global Burden of Disease Study 2019
Material Type:
Article
Add to My Research

Five insights from the Global Burden of Disease Study 2019

The Lancet (British edition), 2020-10, Vol.396 (10258), p.1135-1159 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31404-5 ;PMID: 33069324

Full text available

10
Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline
Material Type:
Article
Add to My Research

Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1474-1494 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02768 ;PMID: 31829902

Full text available

11
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis
Material Type:
Article
Add to My Research

Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis

BMC medical research methodology, 2011-11, Vol.11 (1), p.160-160, Article 160 [Peer Reviewed Journal]

COPYRIGHT 2011 BioMed Central Ltd. ;2011 Davey et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2011 Davey et al; licensee BioMed Central Ltd. 2011 Davey et al; licensee BioMed Central Ltd. ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/1471-2288-11-160 ;PMID: 22114982

Full text available

12
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Material Type:
Article
Add to My Research

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Journal of clinical oncology, 2021-01, Vol.39 (1), p.66-78 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.01933 ;PMID: 33021869

Full text available

13
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Material Type:
Article
Add to My Research

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1378-1388 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02931 ;PMID: 31976786

Full text available

14
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients
Material Type:
Article
Add to My Research

Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients

JNCI : Journal of the National Cancer Institute, 2017-09, Vol.109 (9) [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djx029 ;PMID: 28423407

Full text available

15
Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Material Type:
Article
Add to My Research

Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Clinical cancer research, 2017-12, Vol.23 (23), p.7253-7262 [Peer Reviewed Journal]

2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Dec 1, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-17-1038 ;PMID: 28939744

Full text available

16
Core Outcome Set-STAndards for Reporting: The COS-STAR Statement
Material Type:
Article
Add to My Research

Core Outcome Set-STAndards for Reporting: The COS-STAR Statement

PLoS medicine, 2016-10, Vol.13 (10), p.e1002148-e1002148 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, et al. (2016) Core Outcome Set-STAndards for Reporting: The COS-STAR Statement. PLoS Med 13(10): e1002148. doi:10.1371/journal.pmed.1002148 ;2016 Kirkham et al 2016 Kirkham et al ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, et al. (2016) Core Outcome Set-STAndards for Reporting: The COS-STAR Statement. PLoS Med 13(10): e1002148. doi:10.1371/journal.pmed.1002148 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1002148 ;PMID: 27755541

Full text available

17
Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study
Material Type:
Article
Add to My Research

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study

BMJ (Online), 2020-01, Vol.368 (2), p.l6802-l6802 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6802 ;PMID: 31964641

Full text available

18
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
Material Type:
Article
Add to My Research

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

Blood, 2014-08, Vol.124 (7), p.1174-1182 [Peer Reviewed Journal]

2014 American Society of Hematology ;2014 by The American Society of Hematology. ;2014 by The American Society of Hematology 2014 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2014-02-554725 ;PMID: 24939656

Full text available

19
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
Material Type:
Article
Add to My Research

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial

Journal of clinical oncology, 2021-04, Vol.39 (10), p.1098-1107 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.02447 ;PMID: 33560877

Full text available

20
Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis
Material Type:
Article
Add to My Research

Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis

Journal of clinical oncology, 2017-02, Vol.35 (5), p.515-522 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.68.5081 ;PMID: 27621388

Full text available

Results 1 - 20 of 40,483  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (37,344)

Refine My Results

Creation Date 

From To
  1. Before 1993  (282)
  2. 1993 To 1999  (4,404)
  3. 2000 To 2006  (7,878)
  4. 2007 To 2014  (14,852)
  5. After 2014  (13,117)
  6. More options open sub menu

Language 

  1. English  (39,672)
  2. Japanese  (3,883)
  3. German  (379)
  4. Portuguese  (282)
  5. French  (248)
  6. Spanish  (136)
  7. Swedish  (97)
  8. Russian  (88)
  9. Norwegian  (71)
  10. Chinese  (47)
  11. Turkish  (41)
  12. Italian  (31)
  13. Catalan  (19)
  14. Polish  (19)
  15. Czech  (15)
  16. Korean  (8)
  17. Dutch  (6)
  18. Croatian  (5)
  19. Persian  (4)
  20. More options open sub menu

Searching Remote Databases, Please Wait